Characteristics | Influenza type | P value | |
---|---|---|---|
A (n = 128) | B (n = 109) | ||
Hospitalization | 44 | 35 | 0.783 |
Days of admission | n = 44 | n = 34 | |
Mean, day (SD) | 5.5 (3.2) | 5.7 (2.6) | 0.751 |
Median, days (IQR) | 5 (4–6) | 5 (4–7) | |
Antiviral agent use | 127 (99.2) | 104 (95.4) | 0.097 |
Use of IV antiviral agent | 1 (0.8) | 4 (3.8) | 0.183 |
Total duration of fever | n = 42 | n = 34 | |
Mean, days (SD) | 3.7 (2.6) | 4.3 (2.3) | 0.269 |
Median, days (IQR) | 3 (2–4.75) | 4 (3–5) | |
Fever onset to initiation of antivirals | n = 126 | n = 101 | |
Mean, days (SD) | 1.3 (1.5) | 1.6 (1.7) | 0.074 |
Median, days (IQR) | 1 (0–2) | 1 (1–2) | |
Initiation of antivirals to defervescence | n = 36 | n = 28 | |
Mean, days (SD) | 1.4 (1.3) | 1.8 (2.0) | 0.305 |
Median, days (IQR) | 1 (0.75–2) | 2 (0–2) | |
Antibiotic use | 47 (36.7) | 35 (32.1) | 0.457 |
Supplemental O2 use | 4 (3.1) | 3 (2.8) | > 0.999 |
Intensive care | 2 (1.8) | 0.210 | |
Ventilator care | 1 (0.9) | 0.460 | |
Outcome | |||
Recovered without sequelae | 125 (97.7) | 105 (96.3) | 0.706 |
Recovered with any sequelae | 2 (1.8) | 0.210 | |
Transferred or AMA discharge | 3 (2.3) | 2 (1.8) | > 0.999 |